Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Localized HR-Positive Breast Cancer | Faculty Presentation 1: Advances in the Use of Endocrine Therapy for Localized HR-Positive Breast Cancer — Harold J Burstein, MD, PhD
Localized HR-Positive Breast Cancer | Harold J Burstein, MD, PhD
Posted on 07/13/2026
27:44 |
